Table 3.
Blood perfusion and its corresponding change magnitude in both meridians in the lung meridian intervention group (mean ± SEM, PU).
| Premoxibustion phase | During 15 min moxibustion | 5 min postmoxibustion phase | |||
|---|---|---|---|---|---|
| Phase A | Phase B | Phase C | |||
| The midpoint between LU5 and LU9 | 8.54 ± 0.44 | 9.37 ± 0.47∗∗ | 9.98 ± 0.50∗∗ | 10.35 ± 0.52∗∗ | 10.33 ± 0.53∗∗ |
| — | (0.83 ± 0.15)††## | (1.44 ± 0.21)††## | (1.81 ± 0.27)††## | (1.78 ± 0.28)††## | |
| The midpoint between HT3 and HT7 | 9.68 ± 0.56 | 8.91 ± 0.52∗ | 8.95 ± 0.52∗ | 8.59 ± 0.49∗ | 8.34 ± 0.47∗ |
| — | (−0.77 ± 0.20) | (−0.73 ± 0.18) | (−1.09 ± 0.25) | (−1.34 ± 0.24) | |
| HT3 of the heart meridian | 7.62 ± 0.47 | 7.30 ± 0.46 | 7.28 ± 0.45 | 7.21 ± 0.46 | 7.18 ± 0.45 |
| — | (−0.31 ± 0.14) | (−0.33 ± 0.16) | (−0.40 ± 0.18) | (−0.44 ± 0.19) | |
(i) PU: perfusion units. The values in parentheses were the increase (or decrease) values of PU compared with premoxibustion; (ii) ∗∗p < 0.001 and ∗p < 0.01, compared with premoxibustion PU; (iii) ††p < 0.001, compared with the midpoint between HT3 and HT7; ##p < 0.001, compared with HT3.